Ultrasound assisted dispersive micro solid-phase extraction of four tyrosine kinase inhibitors from serum and cerebrospinal fluid by using magnetic nanoparticles coated with nickel-doped silica as an adsorbent

详细信息    查看全文

• 作者：Mehri Ghazaghi ; Hassan Zavvar Mousavi ; Hamid Shirkhanloo…
• 关键词：Imatinib ; Sunitinib ; Erlotinib ; Nilotinib ; Chronic myeloid leukemia ; Tumor drugs ; Nickel doped silica ; Fe3O4@SiO2 ; Core ; shell nanoparticles
• 刊名：Microchimica Acta
• 出版年：2016
• 出版时间：October 2016
• 年：2016
• 卷：183
• 期：10
• 页码：2779-2789
• 全文大小：1,155 KB
• 刊物类别：Chemistry and Materials Science
• 刊物主题：Chemistry
  Analytical Chemistry
  Inorganic Chemistry
  Physical Chemistry
  Characterization and Evaluation Materials
  Monitoring, Environmental Analysis and Environmental Ecotoxicology
  
• 出版者：Springer Wien
• ISSN：1436-5073
• 卷排序：183

文摘

Nanoparticles (NPs) consisting of a magnetic Fe₃O₄ core and a nickel(II)-doped silica shell were prepared and are shown to be viable materials for selective magnetic extraction of trace quantities of the tyrosine kinase inhibitors (TKIs) imatinib, nilotinib, erlotinib and sunitinib. The NPs were characterized by scanning electron microscopy, transmission electron microscopy, DLS and XRD analysis, and the results revealed a uniform in size (with a typical diameter of 40 nm) and a core-shell structure. The magnetic nanoadsorbent displays good affinity of the TKIs, probably because of the affinity between the Ni(II) ions of the NPs with the nitrogen atoms in the TKIs. The magnetism of the NPs enables them to be quickly separated from serum and cerebrospinal fluid samples. Imidazole, with its higher affinity for Ni(II) than that of the TKIs, was used for desorption of the TKIs from the NPs prior to their quantification by HPLC with UV detection. The detection limits are as low as 200, 480, 130, and 250 ng·L‾^{1 for imatinib, sunitinib, erlotinib, and nilotinib, respectively. The intra-day precisions (RSDs) were lower than 4.0 %. The method displays a wide linear range. It was applied to the determination of TKIs in (spiked) human serum and cerebrospinal fluid and gave recoveries in the range from 94.6 to 98.6 %.}